AstraZeneca scores FDA nod for Imfinzi as first immunotherapy for limited-stage small cell lung cancer
5th December 2024 Uncategorised 0 AstraZeneca scores FDA nod for Imfinzi as first immunotherapy for limited-stage small cell lung cancer
kdunleavy
Thu, 12/05/2024 – 10:37
More: AstraZeneca scores FDA nod for Imfinzi as first immunotherapy for limited-stage small cell lung cancer
Source: fierce